RE: What we have here…7 Aug 2024 19:24
Let’s do a quick reality check.
201 data limited and still awaiting peer review.
201 never picked up by a big pharma (which one would expect if it was so sensational) as many claim.
201 will need reformulation and patent (Adam’s own words)
THX after 3 years and apparently being adept at financing millions perviously according to euda and multiple other sources still haven’t produced so much as a penny in funding after 3 years when the deal was meant to conclude within months.
Adrian admitted via email he and by implication the BOD know not why thx haven’t completed funding (are you kidding me, if I was in business with a potential partner and they couldn’t stipulate with clarity why they hadn’t fulfilled their obligations financially I would be furious to say the least, let alone deeply concerned).
What else can we mention here, where do we start? 😂😂
Seriously would anyone in their right mind invest their money here?
Ummmm…..
Not a chance.